17 results
6-K
EX-99.1
GRCL
Gracell Biotechnologies Inc
17 Jan 24
Current report (foreign)
4:30pm
or independent ethics committee, has sent any written notices or other written correspondence to the Company or any of its Subsidiaries or an investigator
6-K
EX-2.1
GRCL
Gracell Biotechnologies Inc
26 Dec 23
Voting and Support Agreement
8:12am
of the FDA, NMPA nor any other Governmental Entity, nor any institutional review board or independent ethics committee, has sent any written notices
20-F
2020 FY
GRCL
Gracell Biotechnologies Inc
23 Apr 21
Annual report (foreign)
4:04pm
, suspension, clinical hold or termination of clinical trials by us, ethics committee, the FDA, the NMPA or other regulatory authorities for a number of reasons … in necessary interactions with local regulators, ethics committees and other important agencies and contractors due to limitations in employee resources
424B4
qdo3iekahld
8 Jan 21
Prospectus supplement with pricing info
1:42pm
F-1/A
fv96l0gh
7 Jan 21
Registration statement (foreign) (amended)
7:03am
F-1/A
6r65fq
6 Jan 21
Registration statement (foreign) (amended)
12:00am
F-1/A
dbsw6brh mpppj
4 Jan 21
Registration statement (foreign) (amended)
9:30am
F-1
EX-3.1
0oyyf03ghh 4km6502
18 Dec 20
Registration statement (foreign)
4:18pm
F-1
EX-4.4
qdmiy3
18 Dec 20
Registration statement (foreign)
4:18pm
F-1
EX-99.1
ean4tk sq5uxzqol
18 Dec 20
Registration statement (foreign)
4:18pm
F-1
f21i7mwhpw711ntyz
18 Dec 20
Registration statement (foreign)
4:18pm
DRS/A
isr0gsklvjs7ufl1
24 Nov 20
Draft registration statement (amended)
12:00am
DRS/A
EX-3.1
owi7 rbm35r6
24 Nov 20
Draft registration statement (amended)
12:00am
DRS/A
EX-4.4
699iq4q3a3a7bd
24 Nov 20
Draft registration statement (amended)
12:00am
DRS
84c20o
19 Oct 20
Draft registration statement
12:00am
- Prev
- 1
- Next